Patents by Inventor Jae Jin Han

Jae Jin Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240309506
    Abstract: Disclosed herein is a substrate processing apparatus including a process chamber having a reaction space formed therein, a substrate support installed in the reaction space to support a plurality of substrates, the substrate support comprising a susceptor plate, a plurality of vacuum holes formed in a top surface of the susceptor plate, and a vacuum line connecting the plurality of vacuum holes to an external pump, a gas injector comprising a plurality of gas injection units disposed radially to face the substrate support to inject process gas into the reaction space, and a controller configured to adjust a chucking force on the substrates according to a type of gas supplied through the gas injector.
    Type: Application
    Filed: November 1, 2023
    Publication date: September 19, 2024
    Applicant: WONIK IPS CO., LTD.
    Inventors: Jae Jin HAN, Kun Woo PARK, Woo Young PARK, Sung Hwan LEE
  • Patent number: 8871749
    Abstract: Provided is a bone-transplant or bone-filling composition, which comprises a dihydroxybenzoic acid derivative which has been newly demonstrated to increase the activity of osteoblasts and so induce bone formation.
    Type: Grant
    Filed: April 25, 2011
    Date of Patent: October 28, 2014
    Assignee: Cellsafe Co., Ltd.
    Inventor: Jae-Jin Han
  • Patent number: 8815565
    Abstract: Provided is a method for culturing cells, which prevents the possibility of mycoplasma contamination by culturing the cells using biomass extract obtained by culturing a strain with amphidinol productivity, preferably a strain such as Amphidinium klebsii, Amphididinium carterae, and the like belonging to Dinoflagellates, or using a fraction obtained from the extract; and a method for removing mycoplasma contamination of the cells by culturing the cells contaminated by mycoplasma using the amphidinol derivatives. In addition, provided is a method for removing mycoplasma contamination of the cells, including a combination of single cell-isolating enzyme solution treatment and cell aggregate removal.
    Type: Grant
    Filed: November 24, 2010
    Date of Patent: August 26, 2014
    Assignee: Cellsafe Co., Ltd.
    Inventor: Jae-Jin Han
  • Patent number: 8809034
    Abstract: Provided is a method for culturing cells, which prevents the possibility of mycoplasma contamination by culturing the cells using biomass extract obtained by culturing a strain with amphidinol productivity, preferably a strain such as Amphidinium klebsii, Amphididinium carterae, and the like belonging to Dinoflagellates, or using a fraction obtained from the extract; and a method for removing mycoplasma contamination of the cells by culturing the cells contaminated by mycoplasma using the amphidinol derivatives. In addition, provided is a method for removing mycoplasma contamination of the cells, including a combination of single cell-isolating enzyme solution treatment and cell aggregate removal.
    Type: Grant
    Filed: November 26, 2013
    Date of Patent: August 19, 2014
    Assignee: Cellsafe Co., Ltd.
    Inventor: Jae-Jin Han
  • Publication number: 20140093955
    Abstract: Provided is a method for culturing cells, which prevents the possibility of mycoplasma contamination by culturing the cells using biomass extract obtained by culturing a strain with amphidinol productivity, preferably a strain such as Amphidinium klebsii, Amphididinium carterae, and the like belonging to Dinoflagellates, or using a fraction obtained from the extract; and a method for removing mycoplasma contamination of the cells by culturing the cells contaminated by mycoplasma using the amphidinol derivatives. In addition, provided is a method for removing mycoplasma contamination of the cells, including a combination of single cell-isolating enzyme solution treatment and cell aggregate removal.
    Type: Application
    Filed: November 26, 2013
    Publication date: April 3, 2014
    Applicant: CELLSAFE CO., LTD.
    Inventor: Jae-Jin HAN
  • Publication number: 20130053354
    Abstract: Provided is a bone-transplant or bone-filling composition, which comprises a dihydroxybenzoic acid derivative which has been newly demonstrated to increase the activity of osteoblasts and so induce bone formation.
    Type: Application
    Filed: April 25, 2011
    Publication date: February 28, 2013
    Inventor: Jae-Jin Han
  • Publication number: 20120244614
    Abstract: Provided is a method for culturing cells, which prevents the possibility of mycoplasma contamination by culturing the cells using biomass extract obtained by culturing a strain with amphidinol productivity, preferably a strain such as Amphidinium klebsii, Amphididinium carterae, and the like belonging to Dinoflagellates, or using a fraction obtained from the extract; and a method for removing mycoplasma contamination of the cells by culturing the cells contaminated by mycoplasma using the amphidinol derivatives. In addition, provided is a method for removing mycoplasma contamination of the cells, including a combination of single cell-isolating enzyme solution treatment and cell aggregate removal.
    Type: Application
    Filed: December 8, 2010
    Publication date: September 27, 2012
    Applicant: CELLSAFE CO., LTD.
    Inventor: Jae-Jin Han
  • Patent number: 7276501
    Abstract: The present invention relates to 6-(4-substituted-anilino)pyrimidine derivatives useful as an antiviral agent, and more particularly novel 6-(4-substituted-anilino)pyrimidine derivatives having an excellent inhibitory effect on replication of Hepatitis C virus; HCV), represented by the following formula I: in which R represents a C1-C4 straight or branched alkoxycarbonyl group, heterocycliccarbonyl group or carboxyalkyl group; and pharmaceutically acceptable salts thereof, a preparation method thereof, and an antiviral pharmaceutical composition comprising the compound as an effective ingredient. The 6-(4-substituted-anilino)pyrimidine derivatives according to the present invention have an excellent inhibitory effect on replication of Hepatitis C virus (HCV) and thus can be advantageously used as a therapeutic or prophylactic agent of hepatitis C.
    Type: Grant
    Filed: March 25, 2003
    Date of Patent: October 2, 2007
    Assignee: B & C Biopharm
    Inventors: Jong-Woo Kim, Sang-Wook Lee, Geun-Hyung Lee, Jae-Jin Han, Sang-Jin Park, Eul-Yong Park, Joong-Chul Shin
  • Patent number: 7244731
    Abstract: The present invention relates to 6-methylpyridine derivatives useful as an antiviral agent. More particularly, the present invention relates to novel 6-methylpyridine derivatives having an excellent inhibitory effect on replication of Hepatitis C virus (HCV), or pharmaceutically acceptable salts thereof, to a method for preparing thereof, and to an antiviral pharmaceutical composition comprising the compound as an active ingredient.
    Type: Grant
    Filed: October 2, 2003
    Date of Patent: July 17, 2007
    Assignee: B & C Biopharm
    Inventors: Jong-Woo Kim, Sang-Wook Lee, Geun-Hyung Lee, Jae-Jin Han, Sang-Jin Park, Eul-Yong Park, Joong-Chul Shin
  • Publication number: 20060288139
    Abstract: A computer system includes a computer main body provided with a plurality of main body input-output ports; a monitor main body to display an image; a console stand having a console casing with an accommodating space inside and supporting the monitor main body, console input-output ports outside the console casing and connectable to an external device, an integrated port outside the console casing, and a control module controlling an interface between the integrated port and the console input-output port; and a main body/console cable having main body connectors respectively connected to the main body input-output ports, a console connector connected to the integrated port, an integrated cable electrically connecting the plurality of main body connectors and the console connector.
    Type: Application
    Filed: May 25, 2006
    Publication date: December 21, 2006
    Applicant: Samsung Electronics Co., Ltd.
    Inventors: Jae-soon Lee, Jae-jin Han, Joon Lee, Hae-jin Hwang
  • Publication number: 20060269609
    Abstract: The present invention relates to 6-methylpyridine derivatives useful as an antiviral agent. More particularly, the present invention relates to novel 6-methylpyridine derivatives having an excellent inhibitory effect on replication of Hepatitis C virus (HCV), or pharmaceutically acceptable salts thereof, to a method for preparing thereof, and to an antiviral pharmaceutical composition comprising the compound as an active ingredient. The 6-methylpyridine derivatives of the present invention have an excellent inhibitory effect on replication of hepatitis C virus and thus can be advantageously used as a therapeutic or prophylactic agent of hepatitis C.
    Type: Application
    Filed: October 2, 2003
    Publication date: November 30, 2006
    Inventors: Jong-Woo Kim, Sang-Wook Lee, Geun-Hyung Lee, Jae-Jin Han, Sang-Jin Park, Eul-Yong Park, Joong-Chul Shin
  • Publication number: 20050222150
    Abstract: The present invention relates to 6-(4-substituted-anilino)pyrimidine derivatives useful as an antiviral agent, and more particularly novel 6-(4-substituted-anilino)pyrimidine derivatives having an excellent inhibitory effect on replication of Hepatitis C virus; HCV), represented by the following formula I: in which R represents a C1-C4 straight or branched alkoxycarbonyl group, heterocycliccarbonyl group or carboxyalkyl group; and pharmaceutically acceptable salts thereof, a preparation method thereof, and an antiviral pharmaceutical composition comprising the compound as an effective ingredient. The 6-(4-substituted-anilino)pyrimidine derivatives according to the present invention have an excellent inhibitory effect on replication of Hepatitis C virus (HCV) and thus can be advantageously used as a therapeutic or prophylactic agent of hepatitis C.
    Type: Application
    Filed: March 25, 2003
    Publication date: October 6, 2005
    Inventors: Jong-Woo Kim, Sang-Wook Lee, Geun-Hyung Lee, Jae-Jin Han, Sang-Jin Park, Eul-Yong Park, Joong-Chul Shin
  • Publication number: 20040102861
    Abstract: A method of controlling a computer system having an audio reproducing part receiving audio signals from a plurality of application programs generating the audio signals and only reproducing the audio signals of the application programs selected. The computer displays a selection menu from which an application program generating an audio signal desirous of being reproduced is allowed to be selected from among the application programs generating the audio signals. Therefore, only the audio signal from the application program selected is supplied to the audio reproducing part.
    Type: Application
    Filed: June 4, 2003
    Publication date: May 27, 2004
    Applicant: SAMSUNG ELECTRONICS CO., LTD.
    Inventor: Jae-jin Han
  • Patent number: 6306860
    Abstract: Anti-viral agents of formula (1) have been identified. Their preparation method is described. These 2,5-pyridinedicarboxylic acid derivatives or their pharmaceutically acceptable salts are useful in countering the proliferation of viruses such as hepatitis B virus and human immunodeficiency virus.
    Type: Grant
    Filed: November 7, 2000
    Date of Patent: October 23, 2001
    Assignee: Dong Wha Pharm. Inc. Co., Ltd.
    Inventors: Sung Joon Yoon, Sang Wook Lee, Hyeong Su Sim, Yong Kyun Park, Wang Yong Yang, Jong Woo Kim, Jae Jin Han, Je In Yoon, Sang Jin Park, Hee Jeoung Park, Dong Hyuk Sin, Hwan Bong Chang